Literature DB >> 6970004

Factors affecting mortality in biliary tract surgery.

H A Pitt, J L Cameron, R G Postier, T R Gadacz.   

Abstract

Fifteen clinical and laboratory parameters in 155 consecutive patients having bile duct surgery over a 3 year period were analyzed in an effort to define the factors associated with a poor outcome and to define the subpopulation of patients at greatest risk. Ten of the 15 parameters evaluated were found to correlate significantly (p < 0.05) with hospital mortality. Five or more risk factors correlated significantly with mortality (p < 0.0001) and with postoperative renal failure, bacteremia and upper gastrointestinal hemorrhage (p < 0.005). This risk-factor analysis has the advantages of providing information rapidly and employing only clinical observations and readily available laboratory tests. Patients with five or more risk factors should be considered for preoperative percutaneous transhepatic decompression.

Entities:  

Mesh:

Year:  1981        PMID: 6970004     DOI: 10.1016/0002-9610(81)90014-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  65 in total

1.  Impaired response of gastric vessels to prostaglandin E2 in rats with persistent obstructive jaundice.

Authors:  Y Nagahata; Y Azumi; H Moritomo; N Numata; N Kawakita; M Yano; H Onoyama; M Yamamoto
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

2.  Impaired nonspecific cellular immunity in experimental cholestasis.

Authors:  P T Roughneen; D B Drath; A D Kulkarni; B J Rowlands
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

3.  Factors affecting morbidity and mortality in biliary tract surgery.

Authors:  C H Su; F K P'eng; W Y Lui
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

4.  Emergency surgery for severe acute cholangitis. The high-risk patients.

Authors:  E C Lai; P C Tam; I A Paterson; M M Ng; S T Fan; T K Choi; J Wong
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

5.  The role of preoperative biliary decompression in the treatment of bile duct cancer.

Authors:  J Yanagisawa; H Ichimiya; N Kuwano; F Nakayama
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

6.  Altered serum transforming growth factor-beta1 and monocyte chemoattractant protein-1 levels in obstructive jaundice.

Authors:  Shyr-Ming Sheen-Chen; Hock-Liew Eng; Kuo-Sheng Hung
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

7.  Endoscopic management of acute cholangitis in elderly patients.

Authors:  Naresh Agarwal; Barjesh Chander Sharma; Shiv K Sarin
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

8.  Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments.

Authors:  R M Beazley; N Hadjis; I S Benjamin; L H Blumgart
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

9.  Obstructive jaundice alters proliferating cell nuclear antigen expression in rat small intestine.

Authors:  Shyr-Ming Sheen-Chen; Hsin-Tsung Ho; Wei-Jen Chen; Hock-Liew Eng
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

10.  Influence of diabetes on mortality and morbidity following operations for obstructive jaundice.

Authors:  M R Keighley; G Razay; M G Fitzgerald
Journal:  Ann R Coll Surg Engl       Date:  1984-01       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.